Suppr超能文献

采用或不采用抗肥胖药物的全代餐极低热量饮食方案后的体重反弹情况。

Weight regain after total meal replacement very low-calorie diet program with and with-out anti-obesity medications.

作者信息

Cifuentes Lizeth, Galbiati Francesca, Mahmud Hussain, Rometo David

机构信息

Department of Medicine Division of General Internal Medicine University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA.

Department of Medicine Division of Endocrinology, Diabetes, and Hypertension Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.

出版信息

Obes Sci Pract. 2023 Nov 20;10(1):e722. doi: 10.1002/osp4.722. eCollection 2024 Feb.

Abstract

BACKGROUND

Very low-calorie diets (VLCDs) employing total meal replacement (TMR) offer substantial short-term weight loss. Concurrently, anti-obesity medications (AOMs) have shown promise as adjunctive treatments when combined with VLCDs.

AIMS

This study aimed to investigate the impact of adjuvant AOMs on weight loss and weight regain within a comprehensive lifestyle program.

METHODS

This is a retrospective study of patients with obesity enrolled in VLCD/TMR programs,  specifically the OPTIFAST program.

RESULTS

Data from 206 patients (68% women, mean age 52.39 ± 13.05 years, BMI 41.71 ± 7.04 kg/m) were analyzed. Of these, 139 received no AOM (AOM-), while 67 received AOMs (AOM+). Total body weight loss percentages (TWL%) at 6 and 18 months were -17.87% ± 7.02 and -12.10% ± 11.56, respectively. There was no significant difference in 6-month weight loss between the AOM groups. However, the AOM + group exhibited lower weight regain (3.29 kg ± 10.19 vs. 7.61 kg ± 11.96;  = 0.006) and weight regain percentage (WR%) (31.5% ± 68.7 vs. 52.16% ± 64.4;  = 0.04) compared with the AOM- group.

CONCLUSION

The findings highlighted the potential of AOMs and VLCD/TMR as effective strategies for long-term weight management in individuals with obesity.

摘要

背景

采用全餐替代(TMR)的极低热量饮食(VLCD)能实现显著的短期体重减轻。同时,抗肥胖药物(AOM)与VLCD联合使用时,作为辅助治疗显示出了前景。

目的

本研究旨在探讨在综合生活方式计划中,辅助使用AOM对体重减轻和体重反弹的影响。

方法

这是一项对参加VLCD/TMR计划(具体为OPTIFAST计划)的肥胖患者进行的回顾性研究。

结果

分析了206例患者的数据(68%为女性,平均年龄52.39±13.05岁,BMI为41.71±7.04kg/m²)。其中,139例未接受AOM(AOM-),67例接受了AOM(AOM+)。6个月和18个月时的总体重减轻百分比(TWL%)分别为-17.87%±7.02和-12.10%±11.56。AOM组之间6个月体重减轻无显著差异。然而,与AOM-组相比,AOM+组的体重反弹较低(3.29kg±10.19 vs. 7.61kg±11.96;P=0.006),体重反弹百分比(WR%)也较低(31.5%±68.7 vs. 52.16%±64.4;P=0.04)。

结论

研究结果突出了AOM和VLCD/TMR作为肥胖个体长期体重管理有效策略的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9967/10804351/06d29ed1644f/OSP4-10-e722-g003.jpg

相似文献

1
Weight regain after total meal replacement very low-calorie diet program with and with-out anti-obesity medications.
Obes Sci Pract. 2023 Nov 20;10(1):e722. doi: 10.1002/osp4.722. eCollection 2024 Feb.
2
Combination anti-obesity medications to effectively treat bariatric surgery weight regain at an academic obesity center.
Obes Sci Pract. 2022 Sep 24;9(3):203-209. doi: 10.1002/osp4.635. eCollection 2023 Jun.
5
Patients experience with preoperative use of anti-obesity medications and associations with bariatric surgery expectations.
Surg Obes Relat Dis. 2025 Feb;21(2):109-114. doi: 10.1016/j.soard.2024.08.041. Epub 2024 Sep 14.
7
Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
J Manag Care Spec Pharm. 2022 Oct;28(10):1066-1079. doi: 10.18553/jmcp.2022.22116. Epub 2022 Jul 20.
9
Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US.
Front Endocrinol (Lausanne). 2020 May 13;11:290. doi: 10.3389/fendo.2020.00290. eCollection 2020.

引用本文的文献

2
Obesity and its management in primary care setting.
J Diabetes Complications. 2025 Jul;39(7):109045. doi: 10.1016/j.jdiacomp.2025.109045. Epub 2025 Apr 19.

本文引用的文献

1
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity.
JAMA Netw Open. 2022 Sep 1;5(9):e2231982. doi: 10.1001/jamanetworkopen.2022.31982.
4
Homeostatic regulation of food intake.
Clin Res Hepatol Gastroenterol. 2022 Feb;46(2):101794. doi: 10.1016/j.clinre.2021.101794. Epub 2021 Sep 1.
5
A systematic review and meta-analysis of the effectiveness of meal replacements for weight loss.
Obes Rev. 2019 Apr;20(4):569-587. doi: 10.1111/obr.12816. Epub 2019 Jan 24.
6
Effectiveness of a Total Meal Replacement Program (OPTIFAST Program) on Weight Loss: Results from the OPTIWIN Study.
Obesity (Silver Spring). 2019 Jan;27(1):22-29. doi: 10.1002/oby.22303. Epub 2018 Nov 13.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验